Portfolio company
Aelix Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Aelix Therapeutics develops therapeutic vaccines for patients living with HIV to help control the virus without lifelong antiretroviral therapy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aelix
The company develops therapeutic vaccines to treat and eradicate human immunodeficiency virus infections for patients.
Astrivax
This biopharmaceutical company develops thermostable vaccines and immunotherapies to prevent or treat infectious diseases and virus-driven cancers for patients worldwide.
Simplexia
This company develops a vaccine against herpes simplex virus type 2 for patients with genital herpes infections.
ViiV Healthcare
This company develops and provides pharmaceutical medicines for the treatment and prevention of HIV for patients and healthcare professionals.
Excision Biotherapeutics
This biotechnology company develops CRISPR-based gene editing therapies designed to cure chronic viral infectious diseases for patients.
Agenovir
This company develops nuclease-based anti-viral therapeutics to eliminate pathogenic viral genomes for healthcare providers treating patients with persistent viral infections.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Panacos
This biotechnology company develops small molecule antiviral drugs to treat patients with human immunodeficiency virus and other serious infectious diseases.